DArecca James 4
4 · HAEMONETICS CORP · Filed May 20, 2025
Insider Transaction Report
Form 4
DArecca James
EVP, Chief Financial Officer
Transactions
- Award
Common Stock
2025-05-16+7,111→ 21,935 total - Award
Non-qualified Stock Option (Right to Buy)
2025-05-16+15,396→ 15,396 totalExercise: $70.31Exp: 2032-05-16→ Common Stock (15,396 underlying)
Footnotes (4)
- [F1]The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest in three equal annual installments beginning on the first anniversary of the date of grant.
- [F2]Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.
- [F3]This number includes unvested RSUs previously reported.
- [F4]Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.